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Differential interactions of tropomyosin (TM) isoforms with actin can be important for determination of
the thin ﬁlament functions. A mechanism of tropomyosin binding to actin was studied by comparing
interactions of ﬁve aTM isoforms with actin modiﬁed with m-maleimidobenzoyl-N-hydroxysuccinimide
ester (MBS) and with ﬂuorescein-5-isothiocyanate (FITC). MBS attachment sites were revealed with mass
spectrometry methods. We found that the predominant actin fraction was cross-linked by MBS within
subdomain 3. A smaller fraction of the modiﬁed actin was cross-linked within subdomain 2 and between
subdomains 2 and 1. Moreover, investigated actins carried single labels in subdomains 1, 2, and 3. Such
extensive modiﬁcation caused a large decrease in actin afﬁnity for skeletal and smooth muscle tropomyo-
sins, nonmuscle TM2, and chimeric TM1b9a. In contrast, binding of nonmuscle isoform TM5a was less
affected. Isoform’s afﬁnity for actin modiﬁed in subdomain 2 by binding of FITC to Lys61 was intermedi-
ate between the afﬁnity for native actin and MBS-modiﬁed actin except for TM5a, which bound to FITC–
actin with similar afﬁnity as to actin modiﬁed with MBS. The analysis of binding curves according to the
McGhee–von Hippel model revealed that binding to an isolated site, as well as cooperativity of binding to
a contiguous site, was affected by both actin modiﬁcations in a TM isoform-speciﬁc manner.
 2009 Elsevier Inc.Open access under CC BY license.Interactions of actin ﬁlaments with actin-binding proteins and
myosin motors play a central role in muscle contraction and in
many functions of nonmuscle cells [1]. Tropomyosin (TM)1 is a thin
ﬁlament regulatory protein that controls actin interactions with
other proteins. Approximately 40 TM isoforms are expressed in tis-
sue-dependent and developmentally dependent manners. All TM
isoforms are a-helical coiled coils that bind head-to-tail to form con-
tinuous chains along the actin ﬁlament. Mammalian high-molecular-
weight (HMW) isoforms extend along seven actin monomers,
whereas low-molecular-weight (LMW) isoforms bind to six actin
monomers. TM isoforms bind to actin with various afﬁnities and
show different abilities to regulate the actin ﬁlament [2,3]. These dif-wska).
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 license.ferences among TM isoforms are thought to be important factors in
the diversiﬁcation of actin ﬁlaments’ functions in various cell types
[3]. Therefore, precise assembly of actin–TM complexes can be cru-
cial for proper functioning of the actin ﬁlaments.
TM binding to actin is a highly cooperative process. This means
that a TM molecule that is already attached to actin enhances the
binding of a contiguous TM molecule. Cooperativity facilitates full
saturation of the ﬁlament with TM because random binding, which
could form gaps too short to be ﬁlled by one TM, is unfavorable.
Because several factors can affect TM–actin interactions, the mech-
anism of cooperativity is still a matter of debate. Direct association
of N and C termini of the adjacent TMs seems to be the primary
source of cooperativity; however, many data suggest that allosteric
conformational changes in actin are equally important (for a recent
review, see Ref. [4]). Therefore, mapping the sites of TM–actin
interactions and conformational changes within the actin scaffold
associated with TM binding is important for our understanding
of the mechanism of thin ﬁlament assembly.
In several investigations, the above problem has been ap-
proachedby analysis of TMbinding to actinmodiﬁed by limited pro-
teolysis [5–7], mutations [8–10], and attachment of chemical or
ﬂuorescent probes [11,12]. Actin modiﬁed with the heterobifunc-
tional reagent MBS (m-maleimidobenzoyl-N-hydroxysuccinimide
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by tropomyosin/troponin complex [13,14]. However, interpretation
of the results in terms of actin structural changes is speculative
because the localization of modiﬁed residues is not known.
In this work, we analyzed interactions of ﬁve muscle and non-
muscle TM isoforms with actin chemically modiﬁed by attachment
of MBS (MB–actin). To be able to interpret the data, we identiﬁed
the maleimidobenzoyl attachment sites in MBS-labeled actin using
mass spectrometry (MS) methods. We found that subdomain 3 is
the major site of modiﬁcation but that subdomains 2 and 1 also
carry MBS adducts. Comparative analysis of the afﬁnities of TM
isoforms to MB–actin and to ﬂuorescein-5-isothiocyanate (FITC)–
actin (actin derivative modiﬁed in subdomain 2 by attachment of
FITC to Lys61) allowed us to demonstrate that actin subdomains
2 and 3 differentially participate in interactions with different
TM isoforms. Isoform-speciﬁc sequences of TMs determine pre-
ferred sites of TM binding to the actin as well as cooperativity of
the ﬁlament assembly.Materials and methods
Isolation of actin and a-tropomyosin isoforms
G-actin was prepared from chicken skeletal muscle according to
the method of Spudich and Watt [15]. After isolation, the protein
was stored in G-buffer (2 mM Hepes [pH 7.6], 0.2 mM adenosine
triphosphate [ATP], 0.1 mM CaCl2, and 0.01% NaN3) and was used
within a week. Actin concentration was determined spectrophoto-
metrically from absorbance at 290 nm using an extinction coefﬁ-
cient of 0.63 mg ml1 cm1 for 0.1% actin (MW 42,000).
Nonmuscle tropomyosin isoforms TM2, TM5a, and smooth
muscle TM (smTM) used in this study are products of the rat
aTM gene (TPM1). TM1b9a is a chimeric protein that is identical
to TM5a except for the C-terminal 27 amino acids that are encoded
by striated muscle-speciﬁc exon 9a [16]. The proteins were
expressed in the Escherichia coli strain BL21 and then puriﬁed as
described in Ref. [7]. Skeletal muscle aTM (skTM) was obtained
from chicken pectoral muscle according to the method described
in Ref. [17]. Rat and chicken skeletal aTMs share 96% identity
and 97.5% sequence homology (NCBI Entrez Protein accession
numbers AAA21801 and AAA48610). Unlike recombinant proteins
produced in bacteria, skTM is N-terminally acetylated. TM2, smTM,
and skTM are HMW tropomyosin isoforms. TM5a and TM1b9a
belong to the LMW class of TM isoforms. In HMW isoforms
N-terminal amino acids are encoded by exons 1a and 2, whereas
in TM5a and TM1b9a this sequence is replaced by exon 1b. The
sequence encoded by exon 2 (residues 39–80) was either smooth
muscle-speciﬁc 2a or constitutive 2b. The C-terminal sequences
of the isoforms used are encoded either by striated muscle-speciﬁc
exon 9a or constitutive exon 9d found in smooth muscle and
nonmuscle isoforms [18].
Actin modiﬁcation with MBS
Actin modiﬁcation with MBS was performed as described by
Bettache and coworkers [19] with modiﬁcations. G-actin concen-
tration was kept between 2.8 and 3.8 mg/ml. MBS (25 mM in
dimethyl formamide (DMF)) was slowly added under constant stir-
ring to achieve 20-molar excess of the reagent over G-actin. The
labeling was carried out for 16 to 20 h on ice. Unlabeled actin
was polymerized in the presence of 0.1 M KCl and 2 mM MgCl2.
After 1 h incubation at room temperature, F-actin was removed
by 1.5 h ultracentrifugation at 45,000 rpm and 4 C in a Beckman
70Ti rotor. The supernatant containing MBS-labeled actin was
collected and dialyzed overnight against G-buffer. After dialysis,MB–actin was ultracentrifuged as above and the supernatant was
ﬁltered through Millipore 0.2-lm ﬁlters. The protein concentration
was determined densitometrically based on the intensities of
protein bands separated on 12% sodium dodecyl sulfate–polyacryl-
amide gel electrophoresis (SDS–PAGE) and stained with Coomassie
blue. Known concentrations of native actin were used for prepara-
tion of a standard curve. Intensities of protein bands were mea-
sured using the software EasyDens (Cortex Nova, Bydgoszcz,
Poland). The labeled actin was polymerized overnight in the pres-
ence of 0.1 M KCl, 2 mM MgCl2, and 1.5-molar excess of phalloidin
to obtain MB–actin ﬁlaments.
Actin modiﬁcation with FITC
Labeling of actin with FITC was carried out according to the
method of Burtnick [20] with slight modiﬁcations. G-actin was
incubated with a 30-molar excess of FITC for 20 to 24 h on ice in
G-buffer (0.2 mM ATP, 0.1 mM CaCl2, and 2 mM Hepes, pH 8.6).
Unlabeled actin was removed by polymerization in the presence
of 0.1 M NaCl and 2 mM MgCl2, followed by ultracentrifugation
for 2 h at 45,000 rpm in a Beckman 70Ti rotor. To remove unbound
FITC from FITC–actin preparation, the supernatant was gel-ﬁltered
through the Sephadex G-100 column and the collected fractions
were concentrated using a Millipore Amicon Ultra-15 Ultracell
30K concentrator. Labeled protein was dialyzed against G-buffer
(pH 7.6). FITC–actin was ultracentrifuged prior to use to remove
denatured protein. Protein concentration was determined densito-
metrically as described above. The FITC concentration was deter-
mined spectrophotometrically at 460 nm using an absorption
coefﬁcient of 74,500 M1 cm1. The labeling ratio was determined
to be 1.03 ± 0.06. Filamentous FITC–actin was obtained by poly-
merization with 0.1 M KCl, 2 mM MgCl2, and 1.5-molar excess of
phalloidin.
Chemical determination of thiol, amine, and maleimide groups
Reactive thiol groups were measured with Ellman’s colorimetric
assay [21] using 5,50-dithio-bis(2-nitrobenzoic acid) (DTNB) absor-
bance at 412 nm. N-Acetyl-L-cysteine was used for a standard
curve. Actin unfolding was performed by incubation for 6 min with
5% SDS at 56 C. Fully folded actin, as well as unfolded actin, was
analyzed.
The total amount of lysine e-amine was measured after protein
denaturation by incubation for 6 min with 5% SDS at 56 C. The
analysis was done with the use of 2,4,6-trinitrobenzenesulfonic
acid (TNBS), as described in Ref. [22], except that pH was con-
trolled by Na2B4O7 (pH 9.5) and TNBS concentration was 0.005%.
The number of amine groups was calculated using a molar extinc-
tion coefﬁcient of 11,650 M1 cm1 at 335 nm [19].
The presence of free maleimide groups in the MBS-modiﬁed
actin was determined as described by Liu and coworkers [23] using
consecutive reactions of b-mercaptoethanol and DTNB. The quan-
tity of b-mercaptoethanol bound to maleimide groups was deter-
mined spectrophotometrically at 412 nm using a standard curve.
Before the measurements, MB–actin was puriﬁed by ﬁltration on
a Sephacryl S-200 HR column to ensure that all traces of unbound
MBS were removed.
Protein analysis by MS
Nanospray ionization MS was performed on the Applied Biosys-
tems QSTAR XL tandem MS (MS/MS) under the following instru-
mental conditions: declustering potential (DP) was set to 60 V,
and spray voltage applied to the needle (ion source (IS)) was ad-
justed to 0.9 to 1.5 kV. Spectra were deconvoluted using the Bioan-
alyst software package. Before analysis, MB–actin and nonmodiﬁed
Table 1
Determination of free amine and thiol groups in native actin and MB–actin.
Native actin MB–actin
Free Cys374 SH group 0.95 ± 0.01 0.22 ± 0.03
Total reactive SH groups 4.91 ± 0.04 3.16 ± 0.05
Total reactive NH2 groups 15.40 ± 0.45 11.27 ± 0.26
Note. The reactive groups (mol/mol of actin) were determined in the fully folded
proteins (Cys374) and also in unfolded proteins (total reactive groups). Averaged
values from ﬁve or six experiments ± standard errors are shown. Conditions were as
described in Materials and Methods.
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dissolved in a 3:1:0.1 (v/v/v) mixture of water, methanol, and for-
mic acid. The best solubility of MBS-modiﬁed actin was achieved in
a 1:3 (v/v) mixture of formic acid and water. The analysis was
accomplished in the Pomeranian Science and Technology Park
Bio-Lab Centre (Gdynia, Poland).
For generation of tryptic peptide maps, the sample was sepa-
rated on the 10% SDS–PAGE gels and stained with Coomassie blue.
The washing of gel pieces, in-gel trypsin digestion, and peptide elu-
tion were performed as described previously [24].
Liquid chromatography–electrospray ionization–MS/MS (LC–
ESI–MS/MS) analyseswere performed using an Esquire 3000 instru-
ment (Bruker Daltonics, Germany) with a quadrupole ion trap
analyzer and a homemade nanospray ion source. Chromatographic
separations were performed with the aid of an Ultimate nanochro-
matography system (LC Packings/Dionex, Netherlands) [24].
Peptide sequences were identiﬁed using the Mascot engine
(Matrix Science, London, UK). The sequence of chicken skeletal
muscle a-actin was obtained from the Swiss–Prot database (acces-
sion number P68139). Monoisotopic theoretical masses of actin
peptides generated by trypsin digestion were calculated using Pep-
tideMass software [25].
Molecular distance calculation
The distance separating Lys and Cys residues in actin atomic
structure was calculated by the PyMOL 0.99rc6 Open Source (DeL-
ano Scientiﬁc, Palo Alto, CA, USA) using skeletal actin (PDB acces-
sion number 1j6z).
Analysis of tropomyosin binding to actin
Tropomyosin binding to actin was studied by cosedimentation
assay as described in Ref. [7] except that the concentration of NaCl
in the buffer used for the analysis of HMW TM isoform binding was
reduced from 0.15 to 0.10 M.
The apparent association constant (Kapp) of TM to actin was cal-
culated by ﬁtting the experimental data to the Hill equation:
v ¼ n½TMaHKapp=1þ ½TMaHKaHapp; ð1Þ
where v is fraction maximal TM binding to actin, n is maximal TM
bound, [TM] is free [TM], and aH is the cooperativity coefﬁcient.
The equilibrium constant for the association of TM with an iso-
lated binding site (K0) and the equilibrium constant for moving TM
from an isolated binding site to a singly contiguous binding site (x)
were obtained by ﬁtting the data to the McGhee–von Hippel
equation:
t
c
¼ Koð1 n  tÞ ð2x 1Þð1 n  tÞ þ t R2ðx 1Þð1 n  tÞ
 n1
 1 ðnþ 1Þ  tþ R
2ð1 n  tÞ
 
; ð2Þ
where R = {[1  (n + 1)t]2 + 4xt(1  nt)}1/2, t is the number of mo-
les of TM bound per mole of actin, n is the stoichiometry of TM
binding to actin, and c is the concentration of free TM. Nonlinear ﬁt-
ting was done in SigmaPlot (Systat Software, San Jose, CA, USA).
Results
Chemical and electrophoretic analysis of MBS-modiﬁed actin
MBS as a bifunctional reagent can react with a protein’s amine
and thiol groups, potentially leading to internal cross-links and sin-
gle-site modiﬁcations. Because MB–actin was applied previously to
investigations of actin regulation by skeletal TM [13,14], we used itto study mechanisms of interactions between actin and different
TM isoforms.
The protocol for actin modiﬁcation with MBS differed slightly
from the procedure used by Bettache and coworkers [19,26]. To
protect the native structure of actin, the reaction was carried out
at 0 C for a prolonged time (overnight) rather than at 20 C for
2 h. In addition, we did not quench the reaction with dithioeryth-
ritol (DTE) and glycine, which we observed denatures actin.
Despite the milder labeling conditions, the modiﬁcation rendered
actin unable to polymerize at physiological salt concentrations
(0.1 M KCl and 2 mM MgCl2), as with Bettache and coworkers’
original procedure [19]. The addition of phalloidin restored the
ability of MB–actin to polymerize, as reported previously [13].
The extent of actin modiﬁcation with MBS was evaluated by
determination of free amine and thiol groups. Cysteine thiol groups
were determined in a fully folded actin as well as in unfolded pro-
tein in the presence of SDS at high temperature. The only cysteine
residue reactive in native actin (Cys374) was efﬁciently modiﬁed in
MB–actin. The results obtained with unfolded actin show that be-
sides Cys374, one more Cys residue was blocked by MBS (Table 1).
The free amino groups were determined after actin thermal
denaturation in the presence of SDS. We were able to detect only
15 residues, in contrast to Bettache and coworkers [19], who deter-
mined all 19 Lys residues present in native actin. This could be
caused by a partial obstruction of the reaction with TNBS by bind-
ing of SDS to some e-amine groups of lysine [22]. Therefore, to
calculate the number of Lys residues modiﬁed with MBS, we sub-
tracted the reactive amine groups determined in MB–actin from
the groups determined in native actin. The results summarized in
Table 1 indicate that approximately four Lys residues were
modiﬁed by MBS.
MB–actin migrated as doublet bands in the SDS–PAGE (Fig. 1).
The electrophoretic mobility of the upper band was the same as
that of native actin, whereas the lower band migrated slightly fas-
ter. The densitometric ratio of upper to lower band intensities was
1:2.92 ± 0.11. Protein bands of higher molecular weights were not
observed, indicating that the reaction with MBS did not produce
intermolecular actin cross-links. The presence of doublet bands
indicates that protein preparation is heterogeneous and contains
a fraction of intramolecularly cross-linked actin [27].
Characterization of MBS-modiﬁed actin with use of nanospray MS
To determine the stoichiometry of MBS adduct in differentially
labeled actin species, the whole preparation of MB–actin was ana-
lyzed using nanospray MS.
Theoretically, three types of modiﬁcations can be formed during
reactions of MBS with a protein: (i) binding of the label to Cys side
chain, (ii) binding to Lys side chain, and (iii) cross-linking of Lys to
Cys/Lys side chains (Fig. 2). Binding of MBS to Cys SH group leads
to maleimidobenzoic acid formation, causing an increase in protein
molecular weight by 218 Da (Fig. 2, reaction i). Because actin’s N
terminus is acetylated [29], the a-amine group on the N terminus
is inaccessible and the reagent binds only to e-amine groups of
Fig. 1. Electrophoretic analysis of MB–actin. Shown are native actin (A) and MBS-
labeled actin (B) separated on 12% SDS–PAGE and stained in Coomassie blue.
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protein’s molecular weight by only 218 Da (Fig. 2, reaction ii). If
a cysteine or another lysine residue falls within a distance of the
maleimidobenzoyl spacer arm (9.9 Å), a Lys-Cys or Lys-Lys cross-
link can be formed (Fig. 2, reaction iii). The cross-linked protein’s
molecular weight is then increased by 199 Da. An indication that
such a sequence of reactions takes place during the actin modiﬁca-
tion process is the absence of free maleimide groups in our MB–ac-
tin preparation, as veriﬁed by the reaction with b-mercaptoethanol
(see Materials and Methods).
Fig. 3 shows representative deconvoluted nanospray MS spectra
of unmodiﬁed actin (Fig. 3A) and MB–actin (Fig. 3B). The native
actin shows signal at a molecular weight of 41,872 ± 2 Da, in excel-
lent agreement with the theoretical molecular weight calculated
using PeptideMass for skeletal N-acetylated a-actin methylated
at His73 residue (41,872 Da) [29]. A less abundant peak at a molec-
ular weight of 41,956 was always observed in spectra of native
actin. This signal may represent actin fraction modiﬁed by two
azide ions from the antibacterial agent sodium azide. The peak
characteristic for native actin was not observed in the MB–actin
spectrum, showing that all actin molecules in the preparation were
modiﬁed by MBS.
MBS modiﬁcation gives rise to three major actin derivatives
with molecular weights of 42,071 Da (I), 42,289 Da (II), and
42,506 Da (III). As compared with native actin, the molecular
weight of derivative I is shifted by 199 Da. This additional mass
corresponds to the maleimidobenzoyl moiety attached to the pro-Fig. 2. Reactions of MBS with protein side chains (based on Ref. [28]). Shown are bindin
lysine (ii), and cross-linking of lysine and/or cysteine residues (iii).tein during cross-link formation, indicating that derivative I con-
tains single internal cross-link. A mass increase by 417 Da in the
molecular weight of derivative II accounts for the presence of
two adducts. One of the adducts (199 Da) is the cross-link, and
the second one (218 Da) is MB moiety bound to one Lys or Cys res-
idue. The extra mass (634 Da) present in derivative III can be as-
cribed to one cross-linked group (199 Da) and two un-cross-
linked groups (2  218 Da – 1 H+) attached to actin molecule.
Determination of MBS-modiﬁed sites of actin by LC–ESI–MS/MS
To identify the sites of the MBS adducts on actin, we analyzed
the tryptic peptide map of the modiﬁed protein using LC–ESI–
MS/MS. The analysis was done separately for upper and lower
bands of MB–actin excised from SDS gels.
Peptide mass mapping of the upper and lower bands covered 43
and 33% of actin sequence, respectively. To identify the peptides
resolved by this method, observed molecular weights of the pep-
tides were compared with the theoretical molecular weights of
unmodiﬁed actin tryptic peptides generated in PeptideMass. The
peptides that could not be ascribed to any theoretical peptide
masses were identiﬁed by combining molecular weights of the the-
oretical peptides with the molecular weights of MBS adducts. The
search for possible combinations of cross-linked peptides was re-
stricted to the peptides containing Lys and Cys residues, which in
the actin atomic structure are separated by approximately 6 to
11 Å (the length of a linker arm). The results of the search are sum-
marized in Table 2. The peptides found in the upper band are num-
bered from 1 to 5, and peptides found in the lower band are labeled
6 and 7.
Characterization of MB–actin preparation based on chemical and MS
methods
Taken together, the above results show that actin derivatives
migrating in SDSgels in theupper and lowerbands are combinations
of differentially labeled molecules. The nanospray MS detected the
presenceof actinmolecules thatwere either cross-linked (derivativeg of maleimidobenzoyl moiety to cysteine (i), N-hydroxysuccinimide reaction with
Fig. 3. Deconvoluted nanospray MS spectra of native actin (A) and MB–actin (B).
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tives II and III). The peptide mapping strategy shows that, indeed,
suchmodiﬁcations exist. Themodiﬁed sites localized in actin atomic
structure are shown in Fig. 4.
The molecules found in the upper band seem to be cross-
linked between Lys50 and Lys84 and are also labeled on either
Lys315 or Cys374 (derivative II) or on both Lys315 and Cys374
(derivative III) (Fig. 4A). The molecules with a cross-link between
Lys50 and Lys61 can be labeled either on one of the residues
Lys84, Lys315, or Cys374 (derivative II) or on two of the residues
(derivative III) (Fig. 4B). Thus, the upper band is a mixture of actin
molecules cross-linked in subdomain 2 with one or two MBS ad-
ducts attached to subdomains 1 and 3. Because these molecules
do not separate on mini-gels, precise assessment of the popula-
tions of labeled molecules is beyond resolution of this method.
However, intensity of the electrophoretic bands indicates that
derivatives II and III consist of only 25% of the whole MB–actin
preparation.
In the lower band, two types of cross-links were detected. Both
contribute to the dominating derivative I (75% of the MB–actin
preparation) and are localized in subdomain 3. It seems that the
MB molecule initially attached to Lys291 is ﬂexible enough to react
with either Cys285 or Lys326 (Figs. 4C and D). Considering the fact
that maleimide is more selective for Cys than for Lys, the cross-link
with Cys285 is probably dominating; however, quantitative analy-
sis of the ratio of both derivatives is not possible at this stage of
investigations.Table 2
Modiﬁed peptides identiﬁed by ESI–LC–MS/MS.
Observed mass [M+H]+ Calculated Mass (Da) Posi
1 2601.5 2600.2 40–5
51–6
2 3395.2 3392.6 40–5
69–8
3 2188.9 2191 69–8
4 639.1 639.4 313–
5 482.2 484.1 374–
6 1505 1506.9 291
316–
7 1079.7 1079.6 291
285–
a Sulfoxide derivative.
b Methylated.Binding of tropomyosin isoforms to MBS- and FITC-modiﬁed actin
The effect of actin modiﬁcation with MBS on TM binding was
tested with ﬁve a-tropomyosin isoforms: skTM, smTM, nonmuscle
TM2, TM5a, and chimeric TM1b9a. The isoforms share similar se-
quence except for three regions encoded by alternative exons as
described in Materials and Methods. Binding of TM isoforms to na-
tive F-actin and MB–F-actin, measured in a direct cosedimentation
assay, is illustrated in Fig. 5. The apparent equilibrium binding con-
stants (Kapp), shown in Table 3, indicate that actin modiﬁcation re-
duced binding of all studied TM isoforms by more than an order of
magnitude except for TM5a, which binds to MB–actin with an
afﬁnity approximately eightfold weaker than to native actin.
The results suggest that binding of TM isoforms is sensitive to
actin conformation changed by the modiﬁcation with MBS. Be-
cause in our MB–actin preparation the majority of actin molecules
are cross-linked in subdomain 3, one can anticipate that subdo-
main 3 strongly contributed to tropomyosin binding, although
binding of TM5a was affected to a smaller extent.
Gel electrophoresis and MS data showed that approximately
25% of MBS-modiﬁed actins carry adducts in subdomains 1 and
2. Unfortunately, we were unable to separate MB–actin cross-
linked in subdomain 3 from the rest of labeled actins. We showed
in our previous work that involvement of actin subdomain 1 in TM
binding is small given that proteolytic removal of three C-terminal
amino acids reduced afﬁnity for TM isoforms no more than 1.5-fold
[7,30]. Therefore, the major effect of actin labeling with MBStion in sequence Peptide sequence Modiﬁcation sites
0 HQGVMaVGMaGQK K50–K61
1 DSYVGDEAQSK
0 HQGVMaVGMaGQK K50–K84
4 YPIEHbGIITNWDDMaEK
4 YPIEHbGIITNWDDMEK K84
315 MaQK K315
375 CF C374
K K291–K326
326 EITALAPSTMK
K K291–C285
290 CDIDIR
Fig. 4. Actin sites modiﬁed with MBS. Lysine and cysteine residues involved in the reaction with MBS are highlighted in green and blue, respectively. The presence of a cross-
link is marked by a red arrow, and labeling with MBS without cross-link formation is indicated by a red star. (A and B) Actin derivatives migrating in the upper band of SDS
gels. (C and D) Modiﬁed actins migrating in the lower band of SDS gels. Actin subdomains 1 to 4 are indicated in panel D. Actin structure was plotted with the aid of PyMOL
based on skeletal actin coordinates (PDB accession number 1j6z). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to theWeb version of
this article.)
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2 modiﬁcations.
To discern the contributions of both regions to cooperative actin
binding, we tested TM binding to actin modiﬁed in subdomain 2 by
covalent binding of FITC to Lys61 [20]. As shown in Fig. 5 and Table
3, afﬁnities of FITC–actin for muscle TMs, TM2, and TM1b9a were
intermediate between native actin and MB–actin. In contrast, the
afﬁnity constant of FITC–actin for TM5a was reduced eightfold
and its value was close to the afﬁnity of MB–actin.
Cooperativity of TM isoforms binding to modiﬁed actin
According to the model developed by McGhee and von Hippel
[31], two parameters contribute to the overall afﬁnity (Kapp) of a
long ligand binding to a linear lattice. The ﬁrst parameter is an
afﬁnity of a ligand for an isolated site (K0), a site with no other
ligands bound adjacently. The second parameter (x) is a mea-
sure of binding cooperativity and describes an increase in afﬁn-
ity when a ligand’s binding is facilitated by near-neighbor
interactions [4].
Using the McGhee–von Hippel equation, we analyzed the
effects that actin modiﬁcations had on TM’s afﬁnity for an isolated
and contiguous site. In the case of MB–actin, the analysis was re-
stricted to TM5a because we were not able to produce full binding
curves for the other isoforms. The values of K0 andxwere obtained
by ﬁtting experimental points (shown in Fig. 5) to the McGhee–von
Hippel equation (Eq. (2)). The data in Table 3 show that the param-
eters of the overall afﬁnity reduction associated with actin modiﬁ-
cations differed for each of the TM isoforms tested. The strongest
effect of actin modiﬁcations on binding to an isolated site was ob-served for TM5a. In the case of other isoforms, K0 was less affected
or unchanged (smTM). The cooperativity of TM binding was also
differentially affected. Both actin modiﬁcations increased coopera-
tivity of TM5a binding to a contiguous site. In contrast, other iso-
forms tended to bind to FITC actin with lower cooperativity than
to native actin; however, the calculated difference in x was not
statistically signiﬁcant for TM2 and TM1b9a.
Discussion
Eukaryotic cells express multiple TM isoforms that often local-
ize in different cellular compartments. The mechanism that drives
the isoforms to different cellular regions is not known. One possi-
ble explanation is that binding of different TM isoforms is sensitive
to actin conformation that may be determined by cellular location
and the presence of other actin-binding proteins [3]. To analyze the
mechanism of the thin ﬁlament assembly with various TM iso-
forms, we used actin in which the conformation was changed by
covalent modiﬁcations with MBS and FITC.
Using chemical determinations and MS methods, we found that
MBS modiﬁed actin by cross-linking Lys and Cys residues or bind-
ing to a single Lys in actin subdomain 3. Another cross-link was
formed within subdomain 2 and/or between subdomains 2 and
1. Subdomains 2 and 1 can also be modiﬁed by attachment of a sin-
gle label.
The precise location of ﬂuorescein moiety of FITC attached to
Lys61 is not known. However, analysis of the molecular distances
between the Lys61 e-amine group and actin amino acid residues
within the radius of approximately 11 Å (a distance covered by
FITC molecule) suggests that within an actin monomer the sphere
Fig. 5. Effect of actin modiﬁcation with MBS and FITC on its afﬁnity for tropomyosin
isoforms. Binding of the skTM (A), smTM (B), TM2 (C), TM1b9a (D), and TM5a (E) to
native actin (circles), FITC–actin (squares), and MB–actin (triangles) in 5 mM
imidazole (pH 7.0), 2 mM MgCl2, and 100 mM NaCl (or 30 mM NaCl in panel E) was
analyzed as described in Materials and Methods. Symbols show collected exper-
imental points from two to ﬁve experiments. Binding curves were generated by
SigmaPlot by ﬁtting the experimental points to a Hill equation (Eq. (1)).
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subdomain 2.Modiﬁcations with FITC and MBS gradually reduced the afﬁnity
of four muscle and nonmuscle TM isoforms toward actin. This
observation suggests that actin subdomain 2 is important for bind-
ing of these isoforms, but the most important site of interactions is
located in subdomain 3. In contrast, both modiﬁcations had similar
effects on actin binding to nonmuscle TM5a. The latter observation
was striking because MBS modiﬁes actin much more extensively
than does FITC. The data indicate that subdomain 2 strongly con-
tributes to actin interactions with TM5a; however, this does not
rule out involvement of subdomain 3 in binding this isoform. In
the preparation of MB–actin, the molecules cross-linked in subdo-
main 3 are predominant species. If subdomain 3 were not involved
in actin interactions with TM5a, MB–actin would bind to this
tropomyosin with a higher afﬁnity than FITC–actin, which is la-
beled on subdomain 2 only. This suggests that Tm5a binds to a dis-
crete actin site that is similarly distorted by attachment of either
FITC or MBS.
Our results also show that the factor that determines speciﬁcity
of TM’s interactions with actin is not the length of TM but rather its
sequence. Although TM5a and TM1b9a belong to the LMW class of
isoforms, they were differentially affected by both actin modiﬁca-
tions. Composition of the end-to-end overlap complex seems to be
important for positioning of TM on actin. This conclusion is in line
with our previous data obtained for C-terminally truncated actin
[7].
One can speculate that modiﬁcation with MBS had a signiﬁcant
effect on actin afﬁnity for HMW TM isoforms and TM1b9a because
these TMs bind close to the central part of subdomain 3. This sub-
domain was predicted as a major binding region of the skTM by an
atomic model of actin–TM complex obtained by X-ray ﬁber diffrac-
tion [32]. The results obtained for yeast actin mutated in subdo-
main 3 support this notion [9]. However, if we consider our
results in terms of TM orientation on the ﬁlament, it is hard to rec-
oncile them with the three-dimensional reconstructions of elec-
tron microscopy images of actin ﬁlaments complexed with
various TM isoforms. The reconstructions revealed that whereas
skTM made contacts with subdomain 3 in the inner domain of ac-
tin ﬁlament, smTM was shifted toward the outer domain where
interactions with subdomain 2 were more plausible. TM5a was
found at a position indistinguishable from the location of skTM
[33]. Thus, if TM5a binds to the same actin site as skTM, both iso-
forms should display similar sensitivity to actin modiﬁcations used
in this work. The reason for differential binding of the isoforms to
actin modiﬁed with MBS and FITC intrigues us. Our analysis sug-
gests not only that direct actin–TM contacts are responsible for this
phenomenon but also that allosteric changes within actin partici-
pate in TM isoform recognition.
The analysis of actin-binding data according to the McGhee–
von Hippel model revealed that actin modiﬁcations differentially
affected binding cooperativity and the afﬁnity for an isolated site
of each TM isoform. These results support our recent observation
on actin modiﬁed by proteolytic removal of three C-terminal resi-
dues that actin truncation affected TM binding parameters in an
isoform-dependent manner [7]. Because the end-to-end contacts
between TMs were unaltered, the changes in K0 and x observed
in our experiments must be due to conformational changes in actin
caused by the modiﬁcations. Therefore, the cooperativity coefﬁ-
cient must reﬂect TM-induced long-range interactions that are
spread along an actin linear lattice. The idea that actin actively par-
ticipates in the cooperativity of the thin ﬁlament has been pro-
posed previously [34,35]. The ﬁndings of this and previous work
[7] show that actin regions participating in cooperativity are
spread throughout the entire molecule.
Taken together, our results support the idea that TM and actin
are active partners responsible for functional differences of thin ﬁl-
aments working in various cellular environments.
Table 3
Parameters of TM isoforms binding to native actin and modiﬁed actin.
TM isoform Native F-actin MB–F-actin FITC–F-actin
Kapp (lM1) K0 (lM1) x Kapp (lM1) K0 (lM1) x Kapp (lM1) K0 (lM1) x
skTM 3.11 ± 0.13 0.127 ± 0.030 21.8 ± 3.3 <0.1 n.d. n.d. 1.30 ± 0.08 0.082 ± 0.015 16.3 ± 2.9
smTM 1.84 ± 0.03 0.035 ± 0.006 38.7 ± 5.0 <0.1 n.d. n.d. 0.70 ± 0.03 0.034 ± 0.007 22.3 ± 4.1
TM2 1.50 ± 0.06 0.075 ± 0.009 19.3 ± 2.1 <0.1 n.d. n.d. 0.71 ± 0.04 0.039 ± 0.003 17.9 ± 1.4
TM1b9a 5.64 ± 0.91 0.367 ± 0.180 16.6 ± 6.2 <0.1 n.d. n.d. 0.73 ± 0.07 0.065 ± 0.020 15.3 ± 4.4
TM5a 3.87 ± 0.17 0.377 ± 0.094 10.2 ± 2.7 0.49 ± 0.06 0.034 ± 0.005 16.9 ± 2.6 0.58 ± 0.09 0.035 ± 0.008 18.8 ± 3.6
Note. The apparent equilibrium binding constant (Kapp) was obtained by ﬁtting the experimental points shown in Fig. 5 to the Hill equation (Eq. (1)). The afﬁnity for an isolated
site (K0) and the equilibrium constant for moving TM from an isolated binding site to a singly contiguous binding site (x) were obtained by ﬁtting the experimental data to
the McGhee–von Hippel equation (Eq. (2)). Conditions: 5 mM imidazole (pH 7.0), 0.1 M NaCl (or 30 mM NaCl for TM5a), and 2 mM MgCl2. All parameters shown are
averages ± standard errors.
n.d., parameters not determined.
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